Wednesday , June 20 2018

From the Editor

June, 2018

  • 19 June

    June 19, 2018

    A few weeks ago we were  discussing DNA testing and the value this will have in medication choices. This week Steve shares an interview he had with Dr. Jeffrey Mechanick on a topic similar to our DNA discussion as they work their way through transcultural endocrinology and how this new way of …

    Read More »

Latest Articles

June, 2018

  • 19 June

    Don’t Stop: Encouraging Patient Success

    When prescribed lifestyle changes and or medication(s), patients who have diabetes, obesity, hypertension, or any chronic condition that is easy to monitor, even from home, may agree to these changes at first. They can almost immediately get improvements in their numbers. It can be encouraging. For some, seeing those numbers change for the better encourages them to keep on keeping on. However, others may think they are healed and stop treatment. Their numbers may go back to the same or even "worse" than before the treatment.

    Read More »
  • 19 June

    Jeffrey Mechanick 2018 Complete Interview

    Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the AACE 2018  in Boston, MA. Dr. Jeffrey Mechanick, MD, FACE, FACR, FACN, ECNU is Professor of Medicine and Medical Director …

    Read More »
  • 19 June

    Future Use of Technology in Outpatient Care Part 3

    In this week's Homerun Slides, asking the question of how to translate knowledge and implications of pathophysiology, progression, and diabetes complications to the prevention, early diagnosis and optimal treatment of diabetes and its complications.

    Read More »
  • 19 June

    International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #130: Pathogenesis of Type 2 Diabetes Mellitus Part 1

    Normal glucose homeostasis: Any discussion of the pathogenesis of type 2 diabetes mellitus (T2DM) must start with a review of mechanisms involved in the maintenance of normal glucose homeostasis in the basal o postabsorptive state (10–12-h overnight fast) and following ingestion of a typical mixed meal. In the postabsorptive state the great majority of total body glucose disposal takes place in insulin independent tissues.

    Read More »
  • 19 June

    Jeffrey Mechanick 2018 Transcript

    In this exclusive interview transcript, Dr. Jeffrey Mechanick discusses transcultural endocrinology and the different ways diabetes care can be fashioned based on different cultures and ethnicities.

    Read More »

Test Your Knowledge

Clinical Case Vignette: Macronutrients

Mr. Carlson is a man, 52-years of age. He is Caucasian and works as a grocery store manager. His labs show that they were significant for elevated random plasma glucose 166 mg/dL, A1C 7.6% and elevated lipids (TG=175 mg/dL, LDL 148 mg/dL, HDL 38 mg/dL, total cholesterol 221 mg/dL). His physical exam is notable for central abdominal obesity (waist circumference 42”), BP 147/91, HR 72, RR 18, BMI 36 kg/m2, but otherwise normal. He is started on metformin and a dietitian is recommended. The dietitian discusses with him the benefits of medical nutrition therapy on weight, glycemic control, blood pressure, lipid profile, and overall wellbeing. Which following statement regarding macronutrients is true?

Correct

Answer: D. Saturated fat should be <7% of total calories

Educational Critique: Saturated fat should be <7% of the total daily calories. Dietary modifications and the composition of carbohydrates/fats/protein should be adjusted to meet the needs and preferences of the individual patients. Carbohydrate monitoring is still a key component for glycemic control. It can occur in the form of carbohydrate counting, estimation based on experience, or educated food choices. Reduced trans fat intake results in a lower LDL and increased HDL.  — American Dietitians Association

Incorrect

More Articles

June, 2018